Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
VMD Viemed Healthcare Inc
- Stocks
- Healthcare
- NASDAQ: VMD
Price (delayed)
$6.92
Market cap
$273.5M
P/E Ratio
21.63
Dividend/share
N/A
EPS
$0.32
Enterprise value
$270.1M
Viemed Healthcare Inc. is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed's service offerings are focused on effective in-home treatment with clinical
Highlights
The price to earnings (P/E) is 22% lower than the 5-year quarterly average of 27.9 and 16% lower than the last 4 quarters average of 25.9
The revenue has grown by 20% year-on-year and by 3.8% since the previous quarter
VMD's quick ratio is down by 9% since the previous quarter and by 9% year-on-year
VMD's gross margin is down by 3.9% year-on-year
Key stats
What are the main financial stats of VMD
Market
Valuations
Earnings
Shares outstanding
39.52M
Market cap
$273.5M
Enterprise value
$270.1M
Price to earnings (P/E)
21.63
Price to book (P/B)
2.03
Price to sales (P/S)
1.17
EV/EBIT
14.77
EV/EBITDA
6.14
EV/Sales
1.16
Revenue
$232.79M
Gross profit
$136.68M
Operating income
$19.54M
Net income
$12.29M
EBIT
$18.29M
EBITDA
$43.98M
Free cash flow
$10.15M
Per share
Balance sheet
Liquidity
EPS
$0.32
EPS diluted
$0.31
Free cash flow per share
$0.26
Book value per share
$3.41
Revenue per share
$5.9
TBVPS
$3.66
Total assets
$178.08M
Total liabilities
$41.33M
Debt
$6.76M
Equity
$134.76M
Working capital
$13.63M
Debt to equity
0.05
Current ratio
1.38
Quick ratio
1.04
Net debt/EBITDA
-0.08
Margins
Efficiency
Dividend
EBITDA margin
18.9%
Gross margin
58.7%
Net margin
5.3%
Operating margin
8.4%
Return on assets
7.1%
Return on equity
9.6%
Return on invested capital
18.4%
Return on capital employed
12.8%
Return on sales
7.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VMD stock price
How has the Viemed Healthcare stock price performed over time
Intraday
0.14%
1 week
4.53%
1 month
4.85%
1 year
6.96%
YTD
-13.72%
QTD
-4.95%
Financial performance
How have Viemed Healthcare's revenue and profit performed over time
Revenue
$232.79M
Gross profit
$136.68M
Operating income
$19.54M
Net income
$12.29M
Gross margin
58.7%
Net margin
5.3%
The operating income has grown by 34% YoY and by 9% from the previous quarter
The revenue has grown by 20% year-on-year and by 3.8% since the previous quarter
The net income has increased by 19% year-on-year and by 9% since the previous quarter
VMD's gross profit is up by 15% YoY and by 2.6% QoQ
Price vs fundamentals
How does VMD's price correlate with its fundamentals
Growth
What is Viemed Healthcare's growth rate over time
Valuation
What is Viemed Healthcare stock price valuation
P/E
21.63
P/B
2.03
P/S
1.17
EV/EBIT
14.77
EV/EBITDA
6.14
EV/Sales
1.16
The price to earnings (P/E) is 22% lower than the 5-year quarterly average of 27.9 and 16% lower than the last 4 quarters average of 25.9
Viemed Healthcare's EPS has increased by 19% YoY and by 10% QoQ
The P/B is 28% lower than the 5-year quarterly average of 2.8 and 8% lower than the last 4 quarters average of 2.2
The equity is up by 2.6% since the previous quarter and by 2.6% year-on-year
The P/S is 42% below the 5-year quarterly average of 2.0 and 10% below the last 4 quarters average of 1.3
The revenue has grown by 20% year-on-year and by 3.8% since the previous quarter
Efficiency
How efficient is Viemed Healthcare business performance
The ROA is up by 11% YoY and by 8% QoQ
The company's return on invested capital rose by 11% YoY and by 6% QoQ
The ROE has grown by 10% YoY and by 8% from the previous quarter
Viemed Healthcare's return on sales has increased by 5% QoQ
Dividends
What is VMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VMD.
Financial health
How did Viemed Healthcare financials performed over time
VMD's quick ratio is down by 9% since the previous quarter and by 9% year-on-year
The total liabilities is down by 6% since the previous quarter and by 6% year-on-year
The company's debt is 95% lower than its equity
The equity is up by 2.6% since the previous quarter and by 2.6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.